 TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTCQB: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that the Company will present at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. 